Requip XL | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

452 results for “Requip XL”

Trials

View all 293 →

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions

12 participants · First posted Oct 30, 2012

Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions

12 participants · First posted Oct 26, 2012

A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda

50 participants · First posted Jun 13, 2011

Drugs

View all 110 →

xl-220

XL-475

xl-180

Organizations

浙江同伍生物医药有限公司

Cytosorbents

United States

EQUIPO IVI SL

Spain

News

View all 46 →

Elite Pharmaceuticals Secures FDA Approval for Generic Ropinirole Extended-Release Tablets for Parkinson's Disease

Surmodics' Pounce XL Thrombectomy System Receives FDA Clearance

XL-protein Grants Worldwide License to Grifols for PASylation-Enhanced Biopharmaceutical Development

Page 1 of 46